**Author details**

Natassa Pippa\* and Costas Demetzos Division of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece

\*Address all correspondence to: natpippa@pharm.uoa.gr

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**101**

*The Release Kinetics of Melatonin from Innovative Dosage Forms: The Role of the Fractal…*

biopharmaceutical sciences: From classical to fractal and finally to fractional. Pharmaceutical Research. 2011;**28**:1229-1232. DOI: 10.1007/

[9] Kosmidis K, Macheras P. On the dilemma of fractal or fraction kinetics in drug release studies: A comparison between Weibull and Mittag-Leffler functions. International Journal of Pharmaceutics. 2018;**543**:269-273. DOI:

10.1016/j.ijpharm.2018.03.060

[11] Wood B, Rea MS, Plitnick B, Figueiro MG. Light level and duration of exposure determine the impact of self-luminous tablets on melatonin suppression. Applied Ergonomics. 2013;**44**:237-240. DOI: 10.1016/j.

[12] Martarelli D, Casettari L, Shalby KS, Soliman ME, Cespo M, Bonacucina G, et al. Optimization of melatonin dissolution from extended release matrices using artificial neural networking. Current Drug Delivery.

[13] Vlachou M, Kikionis S, Siamidi A, Tragou K, Ioannou E, Roussis V, et al. Modified in vitro release of melatonin loaded in nanofibrous electrospun mats incorporated into monolayered and three-layered tablets. Journal of Pharmaceutical Sciences. 2019;**108**:970- 976. DOI: 10.1016/j.xphs.2018.09.035

[14] Chua HM, Hauet Richer N, Swedrowska M, Ingham S, Tomlin S, Forbes B. Dissolution of intact, divided and crushed Circadin tablets: Prolonged

[10] Reiter RJ, Rosales-Corall SA, Liu XY, Acuna-Castroviejo D, Escames G, Tan DX. Melatonin in the oral cavity: Physiological and pathological implications. Journal of Periodontal Research. 2015;**50**:9-17. DOI: 10.1111/

s11095-011-0370-4

jre.12176

apergo.2012.07.008

2016;**13**:565-573

*DOI: http://dx.doi.org/10.5772/intechopen.91155*

[1] Claustrat B, Leston J. Melatonin: Physiological effects in humans. Neurichirugie. 2015;**61**:77-85. DOI: 10.1016/j.neuchi.2015.03.002

[2] Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin L, Yang SF, et al. Melatonin, a full service anti-cancer agent: Inhibition of initiation, progression and metastasis. International Journal of Molecular Sciences. 2017;**843**:1-47. DOI: 10.3390/

[3] Habtemariam S, Daglia M, Sureda A, Selamoglu Z, Gulhan MF, Nabavi SM. Melatonin and respiratory diseases: A review. Current Topics in Medicinal

Chemistry. 2017;**17**:467-488

[4] Vural EM, van Munster BC, de Roiiij SE. Optimal dosage for melatonin supplementation therapy in older adults: A systematic review of current literature. Drugs & Aging. 2014;**31**:441- 451. DOI: 10.1007/s40266-014-0178-0

[5] Demetzos C, Pippa N. Advanced

drug delivery nanosystems (aDDnSs): A mini review. Drug Delivery. 2014;**21**:250-257. DOI: 10.3109/10717544.2013.844745

[6] Pippa N, Dokoumetzidis A, Demetzos C, Macheras P. On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A review. International Journal of Pharmaceutics. 2013;**456**:340-352. DOI: 10.1016/j.ijpharm.2013.08.087

[7] Pippa N, Dokoumetzidis A, Pispas S, Demetzos C. The interplay between the rate of release from polymer grafted liposomes and their fractal morphology. International Journal of Pharmaceutics.

2014;**465**:63-69. DOI: 10.1016/j.

[8] Dokoumetzidis A, Macheras P. The changing face of the rate concept in

ijpharm.2014.02.010

**References**

ijms18040843

*The Release Kinetics of Melatonin from Innovative Dosage Forms: The Role of the Fractal… DOI: http://dx.doi.org/10.5772/intechopen.91155*
